8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference

Grab before it's gone. Avail 30% Instant Discount

Look what we found for you. Use the code to avail 30% instant discount across all delegate participation opportunities. Get a chance to network with industry leaders and key decision makers. Learn from the best. Grow your knowledge exponentially.

Please fill up the Enquiry Form to reveal the code.

Leading the Immunotherapy Revolution: Pioneering Advances in Immuno-Oncology

Welcome to the 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference, a premier event dedicated to advancing the field of immuno-oncology. Join us on 07th - 8th March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of cancer treatment.

As a prominent Immuno-Oncology Conference, this event offers a unique platform to explore the latest advancements, breakthroughs, and innovations in the field. From antibodies and cellular therapies to immune-checkpoint research, our comprehensive program covers a wide range of topics, ensuring a holistic understanding of the dynamic landscape of immuno-oncology.

Engage in interactive sessions, insightful panel discussions, and thought-provoking keynote speeches delivered by renowned speakers. Contribute to interactive roundtables, where you can deliberate on key topics that are most relevant to your field. Exchange knowledge, network with peers, and foster collaborations with experts from around the world, as we collectively strive to drive progress and inspire hope in the fight against cancer.

WHAT TO EXPECT

Updates in development of ADC’s and Bispecific Ab’s
Immune Checkpoint Inhibitors and Combinations
Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
Biomarkers and Personalized Medicine in IO
CAR-T Cell therapy, TCR Based-Cell Therapy
Tumor microenvironment and Oncolytic Viruses

CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group Leaders, Professors, Assistant Professors, Research fellows, PhDs working on

Monoclonal and Bispecific Antibodies
Cell Therapy
Immune Checkpoint Inhibitors

Exclusive conference to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
Find out new case studies of immune-oncology projects in development
Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
Explore the latest platforms and technologies on the market for development
Discuss the best tool for your research in immune-oncology
Share your work and achievements with your industry peers in the Poster Session

Next-Gen Immuno-Oncology Conference

EVENT OVERVIEW

Leading the Immunotherapy Revolution: Pioneering Advances in Immuno-Oncology

CO-LOCATED CONFERENCES

WHAT TO EXPECT